Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
10.95
-0.90 (-7.59%)
At close: May 30, 2025, 4:00 PM
10.96
+0.01 (0.09%)
After-hours: May 30, 2025, 4:20 PM EDT

Oruka Therapeutics Statistics

Total Valuation

ORKA has a market cap or net worth of $410.35 million. The enterprise value is $38.25 million.

Market Cap 410.35M
Enterprise Value 38.25M

Important Dates

The last earnings date was Wednesday, May 14, 2025, after market close.

Earnings Date May 14, 2025
Ex-Dividend Date n/a

Share Statistics

ORKA has 37.44 million shares outstanding.

Current Share Class 37.44M
Shares Outstanding 37.44M
Shares Change (YoY) n/a
Shares Change (QoQ) -4.97%
Owned by Insiders (%) 2.52%
Owned by Institutions (%) 59.75%
Float 22.63M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.13
P/TBV Ratio 1.13
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 30.03, with a Debt / Equity ratio of 0.00.

Current Ratio 30.03
Quick Ratio 29.78
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -81.79

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -31.06%
Revenue Per Employee n/a
Profits Per Employee -$2.87M
Employee Count 28
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -73.40% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -73.40%
50-Day Moving Average 10.01
200-Day Moving Average 18.93
Relative Strength Index (RSI) 55.45
Average Volume (20 Days) 142,994

Short Selling Information

The latest short interest is 2.72 million, so 7.26% of the outstanding shares have been sold short.

Short Interest 2.72M
Short Previous Month 2.66M
Short % of Shares Out 7.26%
Short % of Float 12.02%
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -113.48M
Pretax Income n/a
Net Income -80.35M
EBITDA n/a
EBIT -113.48M
Earnings Per Share (EPS) -$3.04
Full Income Statement

Balance Sheet

The company has $349.09 million in cash and $947,000 in debt, giving a net cash position of $372.10 million or $9.94 per share.

Cash & Cash Equivalents 349.09M
Total Debt 947,000
Net Cash 372.10M
Net Cash Per Share $9.94
Equity (Book Value) 364.73M
Book Value Per Share 9.66
Working Capital 340.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$83.80 million and capital expenditures -$219,182, giving a free cash flow of -$84.02 million.

Operating Cash Flow -83.80M
Capital Expenditures -219,182
Free Cash Flow -84.02M
FCF Per Share -$2.24
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ORKA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -19.58%
FCF Yield -20.47%
Dividend Details

Analyst Forecast

The average price target for ORKA is $39.71, which is 262.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target $39.71
Price Target Difference 262.65%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on September 3, 2024. It was a reverse split with a ratio of 0.083333333:1.

Last Split Date Sep 3, 2024
Split Type Reverse
Split Ratio 0.083333333:1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a